Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis

BACKGROUND: The efficacy of albendazole therapy in patients with parenchymal neurocysticercosis (NCC) is suboptimal. Plasma levels of albendazole sulfoxide (ASOX), the active metabolite of albendazole, are highly variable among patients. We hypothesized that high ASOX plasma levels during albendazol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Arroyo, Gianfranco, Bustos, Javier A, Lescano, Andres G, Gonzales, Isidro, Saavedra, Herbert, Rodriguez, Silvia, Pretell, E Javier, Bonato, Pierina S, Lanchote, Vera L, Takayanagui, Osvaldo M, Horton, John, Gonzalez, Armando E, Gilman, Robert H, Garcia, Hector H
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853673/
https://ncbi.nlm.nih.gov/pubmed/30715265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars